Skyrizi (risankizumab)

pCPA File Number: 22367

Negotiation Status:

Concluded with an LOI

Indication(s):

For the treatment of adults with moderately to severely active Crohn's disease

Sponsor/Manufacturer:

AbbVie Corporation

CADTH Project Number:

SR0767

pCPA Engagement Letter Issued:

2023-09-26

Negotiation Process Concluded:

2024-01-24